Clinical Trials Browser

Solid Tumors × taxane × 1 year × Clear all

NCT07158918 2025-09-08

ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumors